Krasnykh Olga Petrovna

Title: Innovations in Cancer Treatment by Krasnykh Olga Petrovna

Introduction

Krasnykh Olga Petrovna is a prominent inventor based in Perm, Russia. She has made significant contributions to the field of cancer treatment, holding a total of nine patents. Her work focuses on developing novel compounds that exhibit anti-carcinogenic properties, particularly against leukemia and colon cancer.

Latest Patents

One of her latest patents addresses the treatment of leukemia. This invention encompasses compounds that possess anti-carcinogenic activity against human leukemia. It includes the use of 4-(4-Ethoxy-phenyl)-2-(N'-fluoren-9-ylidene-hydrazino)-2-hydroxy-4-oxo-butyric acid methyl ester (OF-13) and/or 4-Chloro-4-(4-ethoxy-phenyl)-2-(fluoren-9-ylidene-hydrazono)-but-3-enoic acid methyl ester (3F-19) as therapeutic means for eradicating leukemia from the human body. Another significant patent focuses on the treatment of colon cancer. The novel compound disclosed is 4-chloro-4-(4-ethoxy-phenyl)-2-(fluoren-9-ylidene-hydrazono)-but-3-enoic acid methyl ester (3F-19). This compound, alone or in combination with OF-13, shows promise as a therapeutic means for eliminating tumors from the human colon.

Career Highlights

Krasnykh Olga Petrovna is affiliated with the University of Central Florida Research Foundation, Inc. Her research and innovations have garnered attention in the scientific community, contributing to advancements in cancer therapies.

Collaborations

She has collaborated with notable colleagues, including Solodnikov Sergey Yurjevich and D Howard Miles. Their joint efforts have furthered the development of effective cancer treatments.

Conclusion

Krasnykh Olga Petrovna's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. Her contributions continue to pave the way for new therapeutic options for patients battling leukemia and colon cancer.